oral-guinea pig LD50 2620 mg/kg BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)
BEHAVIORAL: TREMOR Journal of the American Pharmaceutical Association, Scientific Edition. Vol. 47, Pg. 479, 1958.
oral-human LD50 143 mg/kg British Medical Journal. Vol. 282, Pg. 199, 1981.
oral-human LD50 357 mg/kg British Medical Journal. Vol. 282, Pg. 199, 1981.
intraperitoneal-mouse LD50 367 mg/kg BEHAVIORAL: ANALGESIA Arzneimittel-Forschung. Drug Research. Vol. 15, Pg. 520, 1965.
oral-mouse LD50 338 mg/kg Toxicology and Applied Pharmacology. Vol. 19, Pg. 20, 1971.
intraperitoneal-rat LD50 1205 mg/kg BEHAVIORAL: TREMOR
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) Studi Sassaresi, Sezione 2. Vol. 57, Pg. 561, 1979.
oral-rat LD50 1944 mg/kg United States Patent Document. Vol. #4636513
oral-child LDLo 50 mg/kg KIDNEY, URETER, AND BLADDER: "CHANGES IN TUBULES (INCLUDING ACUTE RENAL FAILURE, ACUTE TUBULAR NECROSIS)"
LUNGS, THORAX, OR RESPIRATION: ACUTE PULMONARY EDEMA
CARDIAC: OTHER CHANGES American Journal of Emergency Medicine. Vol. 6, Pg. 510, 1988.
oral-child LDLo 140 mg/kg/7D-I BLOOD: "CHANGES IN SERUM COMPOSITION (E.G., TP, BILIRUBIN, CHOLESTEROL)"
BEHAVIORAL: COMA
LIVER: "HEPATITIS (HEPATOCELLULAR NECROSIS), ZONAL" Medical Journal of Australia. Vol. 171, Pg. 472, 1999.
oral-child LDLo 360 mg/kg/2D LIVER: OTHER CHANGES
SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE"
GASTROINTESTINAL: NAUSEA OR VOMITING Journal of Pediatrics. Vol. 92, Pg. 832, 1978.
oral-child TDLo 591 mg/kg/2D-I BLOOD: APLASTIC ANEMIA
LIVER: LIVER FUNCTION TESTS IMPAIRED
KIDNEY, URETER, AND BLADDER: "CHANGES IN TUBULES (INCLUDING ACUTE RENAL FAILURE, ACUTE TUBULAR NECROSIS)" Clinical Pediatrics Vol. 33, Pg. 42, 1994.
oral-child TDLo 801 mg/kg LIVER: OTHER CHANGES
GASTROINTESTINAL: NAUSEA OR VOMITING
BEHAVIORAL: GENERAL ANESTHETIC Pediatrics. Vol. 61, Pg. 68, 1978.
intravenous-dog LDLo 826 mg/kg BEHAVIORAL: ANALGESIA Archives Internationales de Pharmacodynamie et de Therapie. Vol. 149, Pg. 571, 1964.
oral-dog LDLo 2000 mg/kg BLOOD: CHANGES IN SPLEEN
BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 24, Pg. 602, 1993.
oral-human LDLo 143 mg/kg BEHAVIORAL: GENERAL ANESTHETIC British Medical Journal. Vol. 282, Pg. 199, 1981.
oral-human LDLo 357 mg/kg GASTROINTESTINAL: NAUSEA OR VOMITING
BEHAVIORAL: ANOREXIA (HUMAN
BEHAVIORAL: COMA Lancet. Vol. 1, Pg. 66, 1973.
oral-mammal (species unspecified) LDLo 512 mg/kg United States Patent Document. Vol. #4035499
oral-man LDLo 143 mg/kg/24H- BEHAVIORAL: ANOREXIA (HUMAN
LIVER: "HEPATITIS (HEPATOCELLULAR NECROSIS), ZONAL"
LIVER: "JAUNDICE, OTHER OR UNCLASSIFIED" American Journal of Medicine. Vol. 74, Pg. 349, 1983.
oral-man LDLo 714 mg/kg LIVER: OTHER CHANGES Human Toxicology. Vol. 1, Pg. 25, 1981.
oral-man TDLo 9286 ug/kg SENSE ORGANS AND SPECIAL SENSES: OTHER: EYE
SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE"
SENSE ORGANS AND SPECIAL SENSES: OTHER: EAR Allergy. Vol. 50(Suppl
oral-man TDLo 714 mg/kg CARDIAC: EKG CHANGES NOT DIAGNOSTIC OF ABOVE Postgraduate Medical Journal. Vol. 69, Pg. 52, 1993.
|